Jon R. Carnes, President. Mr. Carnes has over 19 years experience investing in a broad range of industries and companies of all sizes. From 1992 to 2000 he managed his own stock trading business, becoming the largest private client of two of the nation’s largest electronic brokerage houses. In 2001 he transitioned from trading to making long-term value investments. In 2004, Jon established Eos’s headquarters in Vancouver, Canada. Mr. Carnes is a Phi Beta Kappa graduate of the University of South Carolina with a degree in business economics.

Contact

News

Team

Case Studies

Investment Strategy & Types

Introduction

Copyright 2004-2012 Eos Global Holdings, 1400-1500 West Georgia Street Vancouver, BC V6G 2Z6


Background

"Eos" is the Greek name of the goddess of the dawn, responsible for providing the morning dew that nourishes the growing plants. Since 2004, Eos has focused on identifying and funding first and second round investments in small and mid sized companies in the U.S., Canada and China. Having completed over 25 investments to date. Eos manages its investments from its headquarters in Vancouver, Canada. Eos currently focuses on identifying and investing in early stage U.S. and Canadian biotechnology and natural resource companies.

 

Commitment

As a long-term investor, our investment is only the first stage of our relationship with portfolio companies. We design long-term growth and financing plans for each company. Each company that passes our due diligence process is assured successful, timely and efficient funding.

Eos focuses on finding early stage companies with superior management performance, capable of achieving substantial market share and high return on invested capital. These three elements make up what Warren Buffett calls a “franchise” or business that is protected from competition due to barriers to new entrants. A franchise is therefore said to have durable competitive advantages.

The best franchises benefit from one or more competitive advantages. First and foremost are demand-oriented advantages such as customer preference, habit, captivity, switching costs, or lack of substitutes. Second are supply advantages such as cost advantages, geography, technology, patents, or experience. Third are economies of scale whereby the largest company due to high fixed overhead and leading market share enjoys substantially lower per unit production costs than its smaller competitors. Companies that lack significant barriers to entry and must therefore compete on a level playing field are still good investments when management is focused on maximizing operational efficiency. Companies fitting any of these criteria should be able to earn high returns for investors.

Public or Private Equity

Eos makes private investments in companies where management agrees to execute a plan leading to higher liquidity and valuation. The liquidity plan should involve an IPO on a suitable exchange (anywhere in the world) or a merger or acquisition.

Eos actively invests in private placements or PIPE’s in existing publicly traded companies. Eos also purchases founder’s shares and other share blocks from existing investors.

Warren Buffett

Warren Edward Buffett (born August 30, 1930, in Omaha, Nebraska) is an American investor, businessman and philanthropist. He is regarded as one of the world's greatest investors and is the largest shareholder and CEO of Berkshire Hathaway. With an estimated net worth of around US$62 billion, he was ranked by Forbes as the richest person in the world as of February 11, 2008.

Often called the "Oracle of Omaha," Buffett is noted for his adherence to the value investing philosophy and for his personal frugality despite his immense wealth. Buffett was featured in the critically acclaimed documentary, "IOUSA", produced with the help of our president, Jon Carnes, who got to meet Warren in Omaha at the movie premiere. Jon thanked Warren for his involvement in the project and Warren offered his congratulations on the success.

Eos Global Holdings
1400-1500 West Georgia Street
Vancouver, BC V6G 2Z6
email: info@eosfunds.com
Tel: (888) 858-5862

Due to the poor performance of our investments we decided effective June 30th, 2011 to liquidate our fund and return the remaining cash to our investors.

4/15/2011, Eos re-opened its Vancouver, British Columbia office.

1/01/2011, Eos refocused its resources on identifying and investing in U.S. and Canadian biotechnology and natural resource companies.

2/12/2010, Eos arranged and funded a $2,000,000 bridge loan to Sichuan based Southwest China Cement, to repay existing debt in advance of a $20 million high-yield debt plus warrants financing to fund the completion of its Ziping cement plant expansion at the heart of the 2008 earthquake devastated region.

12/24/2009, Eos arranged and funded a $1,000,000 bridge loan to MDRNA Inc., (NASDAQ: MRNA) secured by the intellectual property and equipment of the company. MDRNA is a biotechnology company focused on developing therapeutics based on RNA interference (RNAi) techonology.

10/26/2009, Eos made a private equity investment in Shandong Longkang Fruity Juice Co., the exclusive producer of super-premium pears and juice concentrate from the Five Dragon River in Laiyang City.

8/28/2009, Eos completed open market and block purchases of Emisphere Technologies Inc. (OTCBB: EMIS). Emisphere is in late phase III development of an oral version of salmon calcitonin for Novartis, a multi-billion dollar opportunity.

5/17/2009, Eos completed the second closing of its largest investment to date in Southwest China Cement (formerly Sichuan Zhiquan Cement Group), a cement manufacturer in Sichuan. The $40 million convertible preferred stock financing funded technological upgrade and expansion of Zhiquan's existing plants.

10/25/2008, Eos successfully advised and completed the simultaneous exercise of warrants, short-term debt and equity financing totaling $750,000 allowing China Wind Systems (Amex: CWS) to buy rolled ring manufacturing equipment.

9/26/2008, Eos closed its largest investment to date in Southwest China Cement (formerly Sichuan Zhiquan Cement Group), a cement manufacturer in Sichuan. The $40 million convertible preferred stock financing will fund technological upgrade and expansion of Zhiquan's existing plants.

5/22/2008, Eos's largest investor, One Horizon Foundation, provided emergency financial assistance to earthquake victims in Baihua village near the Zhiquan Ziping cement factory.

4/29/2008, Eos completed the block trade purchase of $2 million worth of West China Cement (WCC.L - London Stock Exchange) from a failed hedge fund. WCC's stock had lost half its value due to the hedge fund selling. After Eos bought the shares the stock rebounded and the company successfully completed a $60 million investment from Credit Suisse.

1/20/2008, Eos researched, advised and invested in the $10.0 million preferred stock investment in Sichuan based Tianyin Pharmaceuticals, a leading manufacturer and supplier engaged in the development, manufacturing, marketing and sale of traditional Chinese medicines and modern pharmaceuticals in China. For more information, please visit http://www.tianyinpharma.com/

5/31/2007, Eos researched, advised and invested in the $3.4 million preferred stock investment in China Education Alliance, a leading educational service company offering high-quality online education materials and on-site training and tutoring in China. For more information, please visit http://www.chinaeducationalliance.com